No Detail Found!

Comparison of efficacy in preterm infants with apnoea of prematurity treated with caffeine versus aminophylline

Author(s)
SHEIKH AHMAD Department of Pediatrics, Ghurki Trust Teaching Hospital, Lahore, Pakistan
RIZWAN WASEEM Department of Pediatrics, Ghurki Trust Teaching Hospital, Lahore, Pakistan
SAIMA NAUREEN Department of Pharmacology, Lahore Medical & Dental College, Lahore, Pakistan
Azher Abbas Shah Department of Pediatrics, Gujranwala Medical College, Gujranwala, Pakistan
Abstract
Objective: The objective of the study was to compare the efficacy between infants with apnea of prematurity treated with caffeine versus aminophylline. Study Design: A randomized controlled trial. Place and Duration of Study: Research conducted in Department of Pediatrics, Ghurki Trust Teaching Hospital Lahore from February 2022 to August 2022. Material and Methods: In this study 60 neonates of both male and female genders included, which were delivered preterm and having apnea of prematurity. These neonates were divided into two groups randomly; with one group receiving intravenous caffeine while the other receiving intravenous aminophylline. Outcome variable was efficacy of treatment which was labeled if there was no episode of apnea for 24 hours after the treatment started. Results: Mean number of apnea episodes in first 24 hours period was 6.15 ± 2.61. Efficacy of treatment was higher significantly in neonates receiving caffeine as compared to conventional practice of aminophylline (86.7% as compared to 40.0%; p-value <0.001). Conclusion: In the present study, intravenous caffeine was found more efficacious than intravenous aminophylline for the management of preterm neonates with apnea of prematurity.
Publication Details
Page(s) 128-132
DOI DOI not available
Published Journal: Pakistan Paediatric Journal, Volume: 47, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Caffeine, Aminophylline, Apnea of prematurity (AOP)
0

Citations

0

Downloads

49

Views